Bangshang Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bangshang Zhu has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
Yue Su
School of Chemistry and Chemical Engineering State Key Laboratory of Metal Matrix Composites Shanghai Jiao Tong University Shanghai 200240 China
9 shared publicationsXinyuan Zhu
School of Chemistry and Chemical Engineering State Key Laboratory of Metal Matrix Composites Shanghai Jiao Tong University Shanghai 200240 China
8 shared publications- Xinyuan Zhu
Shanghai Jiao Tong University
8 shared publications Yongjia Liu
Instrumental Analysis Center, Shanghai Jiao Tong University, Shanghai 200240, China
8 shared publicationsDeyue Yan
School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, People's Republic of China
6 shared publicationsChunlai Tu
School of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, People’s Republic of China
4 shared publications
Latest Publications
- 8 November 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (11) , 18863-18872
Full-Color and Switchable Circularly Polarized Light from a Macroscopic Chiral Dendritic Film through a Solid-State Supramolecular Assembly
Chiral materials displaying chirality across multiple length scales have attracted increasing interest due to their potential applications in diverse fields. Herein, we report an efficient approach for the construction of macroscopic crystal dendrites with hierarchical chirality based on an in situ solid assembly in a block copolymer film. Chiral fluorescent crystals are formed by enantiopure d-/l-dibenzoyl tartaric acid and pyrenecarboxylic acid in a poly(1,4-butadiene)-b-poly(ethylene oxide) film. The chiro-optical activity of the crystalline dendrites can be greatly amplified in the absorption and scattering regions and goes along with the dimension of dendrites. Notably, the chiral dendrites exhibited strong circularly polarized luminescence emission with a high dissymmetric factor (0.03). The enhancement of the quantum yield of the chiral film was up to 28%, which was 14 times higher that of the corresponding fluorescent molecules. The circularly polarized emission bands of the films can be fine-tuned by contriving the emissive bands of fluorescent molecules. More importantly, the chiral signals are able to be wiped when the fluorescent group photodimerizes under UV irradiation. This work provides an efficient way to develop functional materials through solid self-assembly.
- 8 November 2022
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (11) , 18863-18872
Full-Color and Switchable Circularly Polarized Light from a Macroscopic Chiral Dendritic Film through a Solid-State Supramolecular Assembly
Chiral materials displaying chirality across multiple length scales have attracted increasing interest due to their potential applications in diverse fields. Herein, we report an efficient approach for the construction of macroscopic crystal dendrites with hierarchical chirality based on an in situ solid assembly in a block copolymer film. Chiral fluorescent crystals are formed by enantiopure d-/l-dibenzoyl tartaric acid and pyrenecarboxylic acid in a poly(1,4-butadiene)-b-poly(ethylene oxide) film. The chiro-optical activity of the crystalline dendrites can be greatly amplified in the absorption and scattering regions and goes along with the dimension of dendrites. Notably, the chiral dendrites exhibited strong circularly polarized luminescence emission with a high dissymmetric factor (0.03). The enhancement of the quantum yield of the chiral film was up to 28%, which was 14 times higher that of the corresponding fluorescent molecules. The circularly polarized emission bands of the films can be fine-tuned by contriving the emissive bands of fluorescent molecules. More importantly, the chiral signals are able to be wiped when the fluorescent group photodimerizes under UV irradiation. This work provides an efficient way to develop functional materials through solid self-assembly.
- 1 December 2021
- Published by Elsevier in Chinese Chemical Letters
- Vol. 32 (12) , 3988-3992
Tunable construction of transition metal-coordinated helicene cages
- 1 December 2021
- Published by Elsevier in Chinese Chemical Letters
- Vol. 32 (12) , 3988-3992
Tunable construction of transition metal-coordinated helicene cages
- 1 January 2021
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 120, 111655
Silver-hydroxyapatite nanocomposites prepared by three sequential reaction steps in one pot and their bioactivities in vitro
- 1 January 2021
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 120, 111655
Silver-hydroxyapatite nanocomposites prepared by three sequential reaction steps in one pot and their bioactivities in vitro
- 9 November 2020
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (2) , e2000573
Hydroxyapatite–Bovine Serum Albumin–Paclitaxel Nanoparticles for Locoregional Treatment of Osteosarcoma
Osteosarcoma is the most primary type of bone tumor occurring in the pediatric and adolescent age groups. In order to obtain the most appropriate prognosis, both tumor recurrence inhibition and bone repair promotion are required. In this study, a ternary nanoscale biomaterial/antitumor drug complex including hydroxyapatite (HA), bovine serum albumin (BSA) and paclitaxel (PTX) is prepared for post‐surgical cancer treatment of osteosarcoma in situ. The HA–BSA–PTX nanoparticles, about 55 nm in diameter with drug loading efficiency (32.17 wt%), have sustained release properties of PTX and calcium ions (Ca2+) and low cytotoxicity to human fetal osteoblastic (hFOB 1.19) cells in vitro. However, for osteosarcoma (143B) cells, the proliferation, migration, and invasion ability are significantly inhibited. The in situ osteosarcoma model studies demonstrate that HA–BSA–PTX nanoparticles have significant anticancer effects and can effectively inhibit tumor metastasis. Meanwhile, the detection of alkaline phosphatase activity, calcium deposition, and reverse transcription‐polymerase chain reaction proves that the HA–BSA–PTX nanoparticles can promote the osteogenic differentiation. Therefore, the HA–BSA–PTX nanodrug delivery system combined with sustained drug release, antitumor, and osteogenesis effects is a promising agent for osteosarcoma adjuvant therapy.
- 9 November 2020
- Published by Wiley in Advanced Healthcare Materials
- Vol. 10 (2) , e2000573
Hydroxyapatite–Bovine Serum Albumin–Paclitaxel Nanoparticles for Locoregional Treatment of Osteosarcoma
Osteosarcoma is the most primary type of bone tumor occurring in the pediatric and adolescent age groups. In order to obtain the most appropriate prognosis, both tumor recurrence inhibition and bone repair promotion are required. In this study, a ternary nanoscale biomaterial/antitumor drug complex including hydroxyapatite (HA), bovine serum albumin (BSA) and paclitaxel (PTX) is prepared for post‐surgical cancer treatment of osteosarcoma in situ. The HA–BSA–PTX nanoparticles, about 55 nm in diameter with drug loading efficiency (32.17 wt%), have sustained release properties of PTX and calcium ions (Ca2+) and low cytotoxicity to human fetal osteoblastic (hFOB 1.19) cells in vitro. However, for osteosarcoma (143B) cells, the proliferation, migration, and invasion ability are significantly inhibited. The in situ osteosarcoma model studies demonstrate that HA–BSA–PTX nanoparticles have significant anticancer effects and can effectively inhibit tumor metastasis. Meanwhile, the detection of alkaline phosphatase activity, calcium deposition, and reverse transcription‐polymerase chain reaction proves that the HA–BSA–PTX nanoparticles can promote the osteogenic differentiation. Therefore, the HA–BSA–PTX nanodrug delivery system combined with sustained drug release, antitumor, and osteogenesis effects is a promising agent for osteosarcoma adjuvant therapy.
- 6 March 2020
- Published by Taylor & Francis in Nanomedicine
- Vol. 15 (7) , 661-676
Development of A Multifunctional Gold Nanoplatform for Combined Chemo-Photothermal Therapy Against Oral Cancer
Aim: To design and fabricate a multifunctional drug-delivery nanoplatform for oral cancer therapy. Materials & methods: Polyethylene glycol-stabilized, PDPN antibody (PDPN Ab)- and doxorubicin (DOX...
- 6 March 2020
- Published by Taylor & Francis in Nanomedicine
- Vol. 15 (7) , 661-676
Development of A Multifunctional Gold Nanoplatform for Combined Chemo-Photothermal Therapy Against Oral Cancer
Aim: To design and fabricate a multifunctional drug-delivery nanoplatform for oral cancer therapy. Materials & methods: Polyethylene glycol-stabilized, PDPN antibody (PDPN Ab)- and doxorubicin (DOX...
- 11 February 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 8 (10) , 2128-2138
Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy
Combinational photo-based approaches with enhanced efficacy for cancer therapy have garnered increasing attention in recent years. In this work, a multifunctional system for synergistic photothermal and photodynamic cancer therapy was successfully prepared. The system consists of gold nanoflowers (AuNFs) conjugated with Chlorin e6 (Ce6), and then coated with a polydopamine (PDA) layer. AuNFs with diameters around 80 nm and a broad absorbance in the visible–near infrared (Vis–NIR) range of 500 to 800 nm, were successfully synthesized by a two-step process at 0 °C, using HAuCl4, ascorbic acid (AA), and hydroxylamine hydrochloride (NH2OH·HCl) as the reactants. Glutathione (GSH) molecules chemically anchored to the gold surfaces were used to provide addressable sites for Ce6 conjugated to GSH-AuNFs through an amidation reaction. A PDA layer was then wrapped outside the Ce6-GSH-AuNFs via self-polymerization of dopamine, which provided additional chemical modification and functionalization. Finally, the multifunctional PDA-Ce6-GSH-AuNFs were obtained. The content of Ce6 incorporated into the AuNFs was 14.0 wt%, and the singlet oxygen yield of PDA-Ce6-GSH-AuNFs was approximately 91.0% of that of free Ce6. PDA-Ce6-GSH-AuNFs showed better photothermal conversion efficiency (η = 23.6%), lower cytotoxicity, and faster cell internalization. Both in vitro and in vivo investigation of the combined treatment with a near-infrared (NIR) laser (660 nm for photodynamic therapy, and 808 nm for photothermal therapy) demonstrated that PDA-Ce6-GSH-AuNFs had excellent phototoxicity and synergistic effects of killing cancer cells. Hence, PDA-Ce6-GSH-AuNFs are a dual phototherapeutic agent that exhibits photodynamic and photothermal therapeutic effects and has potential application in enhanced cancer therapy.
- 11 February 2020
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 8 (10) , 2128-2138
Chlorin e6 and polydopamine modified gold nanoflowers for combined photothermal and photodynamic therapy
Combinational photo-based approaches with enhanced efficacy for cancer therapy have garnered increasing attention in recent years. In this work, a multifunctional system for synergistic photothermal and photodynamic cancer therapy was successfully prepared. The system consists of gold nanoflowers (AuNFs) conjugated with Chlorin e6 (Ce6), and then coated with a polydopamine (PDA) layer. AuNFs with diameters around 80 nm and a broad absorbance in the visible–near infrared (Vis–NIR) range of 500 to 800 nm, were successfully synthesized by a two-step process at 0 °C, using HAuCl4, ascorbic acid (AA), and hydroxylamine hydrochloride (NH2OH·HCl) as the reactants. Glutathione (GSH) molecules chemically anchored to the gold surfaces were used to provide addressable sites for Ce6 conjugated to GSH-AuNFs through an amidation reaction. A PDA layer was then wrapped outside the Ce6-GSH-AuNFs via self-polymerization of dopamine, which provided additional chemical modification and functionalization. Finally, the multifunctional PDA-Ce6-GSH-AuNFs were obtained. The content of Ce6 incorporated into the AuNFs was 14.0 wt%, and the singlet oxygen yield of PDA-Ce6-GSH-AuNFs was approximately 91.0% of that of free Ce6. PDA-Ce6-GSH-AuNFs showed better photothermal conversion efficiency (η = 23.6%), lower cytotoxicity, and faster cell internalization. Both in vitro and in vivo investigation of the combined treatment with a near-infrared (NIR) laser (660 nm for photodynamic therapy, and 808 nm for photothermal therapy) demonstrated that PDA-Ce6-GSH-AuNFs had excellent phototoxicity and synergistic effects of killing cancer cells. Hence, PDA-Ce6-GSH-AuNFs are a dual phototherapeutic agent that exhibits photodynamic and photothermal therapeutic effects and has potential application in enhanced cancer therapy.
- 1 November 2019
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 183, 110454
An enzyme-responsive membrane for antibiotic drug release and local periodontal treatment
- 1 November 2019
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 183, 110454
An enzyme-responsive membrane for antibiotic drug release and local periodontal treatment
- Open Access
- 8 October 2019
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 1 (2) , 152-162
Preparation and Characterization of Paclitaxel/Chitosan Nanosuspensions for Drug Delivery System and Cytotoxicity Evaluation In Vitro
- 8 October 2019
- Published by Springer Nature in Advanced Fiber Materials
- Vol. 1 (2) , 152-162
Open AccessPreparation and Characterization of Paclitaxel/Chitosan Nanosuspensions for Drug Delivery System and Cytotoxicity Evaluation In Vitro
- 26 November 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (6) , 1992-2001
Paclitaxel/Chitosan Nanosupensions Provide Enhanced Intravesical Bladder Cancer Therapy with Sustained and Prolonged Delivery of Paclitaxel
Bladder cancer (BC) is a very common cancer and more than half of bladder cancers are non-muscle-invasive bladder cancer (NMIBC). After postoperative tumor resection,The chemotherapy intravesical instillation is recommended as a standard treatment to significantly reduce recurrences. Nanomedicines mediated delivery of chemotherapeutic agent targeting cancer could provide a solution to obtain longer residence time and high bioavailability of anti-cancer drug. The approach described here provides a nanomedicine with sustained and prolonged delivery of paclitaxel and enhanced intravesical bladder cancer therapy, which is paclitaxel/chitosan (PTX/CS) nanosupensions (NSs). The positive charged PTX/CS NSs exhibited a rod-shaped with mean diameter about 200 nm. They have good dispersivity in water without any protective agents, and the positively charged properties make them easy to be adsorbed on the inner mucosa of bladder through electrostatic adsorption. PTX/CS NSs also had a high drug-loading efficiency and sustained release of paclitaxel which could be prolonged over 10 days. Cell experiments in vitro demonstrated that PTX/CS NSs had good biocompatibility and effective bladder cancer cell proliferation inhibition. The significant anti-cancer efficacy against intravesical bladder cancer was verified by in situ bladder cancer model. The paclitaxel/chitosan nanosupensions could provide sustained chemotherapeutic agents delivery with significant anti-cancer efficacy against intravesical bladder cancer.
- 26 November 2018
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 1 (6) , 1992-2001
Paclitaxel/Chitosan Nanosupensions Provide Enhanced Intravesical Bladder Cancer Therapy with Sustained and Prolonged Delivery of Paclitaxel
Bladder cancer (BC) is a very common cancer and more than half of bladder cancers are non-muscle-invasive bladder cancer (NMIBC). After postoperative tumor resection,The chemotherapy intravesical instillation is recommended as a standard treatment to significantly reduce recurrences. Nanomedicines mediated delivery of chemotherapeutic agent targeting cancer could provide a solution to obtain longer residence time and high bioavailability of anti-cancer drug. The approach described here provides a nanomedicine with sustained and prolonged delivery of paclitaxel and enhanced intravesical bladder cancer therapy, which is paclitaxel/chitosan (PTX/CS) nanosupensions (NSs). The positive charged PTX/CS NSs exhibited a rod-shaped with mean diameter about 200 nm. They have good dispersivity in water without any protective agents, and the positively charged properties make them easy to be adsorbed on the inner mucosa of bladder through electrostatic adsorption. PTX/CS NSs also had a high drug-loading efficiency and sustained release of paclitaxel which could be prolonged over 10 days. Cell experiments in vitro demonstrated that PTX/CS NSs had good biocompatibility and effective bladder cancer cell proliferation inhibition. The significant anti-cancer efficacy against intravesical bladder cancer was verified by in situ bladder cancer model. The paclitaxel/chitosan nanosupensions could provide sustained chemotherapeutic agents delivery with significant anti-cancer efficacy against intravesical bladder cancer.
- 1 February 2018
- Published by IOP Publishing in Materials Research Express
- Vol. 5 (2) , 025002
Synthesis and characterization of pure strontium apatite particles and nanoporous scaffold prepared by dextrose-templated method
- 1 February 2018
- Published by IOP Publishing in Materials Research Express
- Vol. 5 (2) , 025002
Synthesis and characterization of pure strontium apatite particles and nanoporous scaffold prepared by dextrose-templated method